Nvidias Blockbuster Earnings Reveal 200 Billion Edge Computing Opportunity and China Market Challenges Reid Hoffman Raises 246 Million for AI CancerResearch Startup Manas AI Veralto Corporation Stock Outlook Analyzing Wall Street Sentiment Microsoft Signals Potential 190 Billion Capital Spending by 2026 Amid Rising Memory Costs Dodgers Star Mookie Betts Calls for Increased Fan Support Amid Slump Trumps Q1 Portfolio Disclosures Reveal Nvidia Stake Alongside HighProfile Intel Trades DV Q1 2026 Earnings EPS Misses Estimates Amid Competitive Landscape HOOD Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty Shares Edge Higher BMRA Q1 2026 Earnings Loss of 044 Per Share Amid No Revenue Disclosure COLD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress RILYT Q1 2024 Earnings Negative EPS of 171 Amidst No Revenue Disclosure Stock Declines TFX Q1 2026 Earnings Earnings Beat Drives Modest Share Gain Johnson Controls International JCI Edges Higher on Moderate Volume Holding Above Key Support Highview Merger Corp Warrants HVMCW Trading Flat at 030 as Support Holds Steady Banco Santander Brasil BSBR Slips 3 as Stock Approaches Critical Support Zone Eaton Vance RiskManaged Diversified Equity Income Fund ETJ Holds Steady as Support Levels Come into Focus Tevogen Bio Holdings TVGN Slides 105 as Selling Pressure Intensifies Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Gladstone Investment Corporation GAINN Q1 2026 Earnings EPS Misses Estimates by 88 as Investment Income Pressures Persist UMH Properties Inc UMH Slips 097 as Stock Tests Key Support Levels Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance EPAM Systems Holds Steady Above Key Support After Modest Gain Masonglory Limited MSGY Surges 786 Testing Key Resistance Near 054 First United Corporation FUNC Slips 107 as Regional Bank Pressures Persist ADSTEC ENERGY PLC Warrant ADSEW Declines 1348 as Support Levels Approach Lipocine Inc LPCN Shows Modest Uptick Trading Near Key Resistance Level Palvella Therapeutics PVLA Gains 316 as Bullish Momentum Builds Toward 12347 Resistance